RESEARCH / DISCOVERY
← Back to the library

[Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB].

[Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB].

Read the original publication

A plain-language reading has not been prepared for this paper yet.

Original abstract

Overactive bladder (OAB) is a common autonomic disorder due mostly to lesions in the micturition-inhibiting area (D1 dopaminergic pathway in the basal ganglia) in Parkinson's disease (PD) and dementia with Lewy bodies (DLB). anticholinergic drugs are the mainstay in the treatment of OAB. However, since 1997, anticholinergic adverse events on the cognitive function have been recognized. Drugs with less lipophilic, less permeable through the blood-brain barrier are the choice in the treatment of OAB in elderly neurologic patients.

Explore another example or bring your own paper

Pasted text and PDF extraction stay on this computer. The local guide explains terms and surfaces passages; rewriting requires a configured local model. Scanned PDFs need OCR first.

RECORD & PROVENANCE